Genetic biomarkers incorporate mutations in the amyloid precursor protein (APP) and presenilin genes (PSEN1 and PSEN2) [23] that are responsible for early-onset AD as well as a major genetic risk factor for late-onset AD, the apolipoprotein E gene (APOE). Here, APP is linked to Alzheimer disease.